stella
beta
Postoperative Radiotherapy Combined With Nimotuzumab Followed by Benmelstobart in High-Risk Patients With Head and Neck Squamous Cell Carcinoma — Stella
Recruiting
Back to Head & Neck Squamous Cell Carcinoma trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Shanghai 9th people's hospital, Shanghai
View full record on ClinicalTrials.gov